Literature DB >> 23709699

Cell therapies: careful translation from animals to patients.

Sean I Savitz1.   

Abstract

Entities:  

Keywords:  bone marrow; cell therapy; inflammation; repair

Mesh：

Year:  2013        PMID： 23709699      PMCID： PMC4218778          DOI： 10.1161/STROKEAHA.112.679605

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  22 in total

1.  Behavioral alterations in Lewis rats following two-day continuous 3-nitropropionic acid administration.

Authors:  J D Newcomb; W D Brown; A I Rodriguez; S Garbuzova-Davis; S Saporta; P R Sanberg; A E Willing
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

Review 2.  Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic.

Authors:  Zheng Gang Zhang; Michael Chopp
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

3.  Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia.

Authors:  Katsuya Komatsu; Osamu Honmou; Junpei Suzuki; Kiyohiro Houkin; Hirofumi Hamada; Jeffery D Kocsis
Journal:  Brain Res       Date:  2010-04-09       Impact factor: 3.252

4.  Determination of the therapeutic time window for human umbilical cord blood mononuclear cell transplantation following experimental stroke in rats.

Authors:  Johannes Boltze; Uwe R Schmidt; Doreen M Reich; Alexander Kranz; Klaus G Reymann; Maria Strassburger; Donald Lobsien; Daniel-Christoph Wagner; Annette Förschler; Wolf-Rüdiger Schäbitz
Journal:  Cell Transplant       Date:  2011-12-13       Impact factor: 4.064

5.  Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke.

Authors:  Maurício A G Friedrich; Maurer P Martins; Mariana D Araújo; Charles Klamt; Leonardo Vedolin; Bernardo Garicochea; Eduardo F Raupp; Jeber Sartori El Ammar; Denise Cantarelli Machado; Jaderson C da Costa; Raul G Nogueira; Paulo Henrique Rosado-de-Castro; Rosalia Mendez-Otero; Gabriel R de Freitas
Journal:  Cell Transplant       Date:  2012       Impact factor: 4.064

6.  Intravenous autologous bone marrow mononuclear cells for ischemic stroke.

Authors:  Sean I Savitz; Vivek Misra; Mallik Kasam; Harrinder Juneja; Charles S Cox; Susan Alderman; Imo Aisiku; Siddhartha Kar; Adrian Gee; James C Grotta
Journal:  Ann Neurol       Date:  2011-07       Impact factor: 10.422

7.  Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model.

Authors:  Johannes Boltze; Björn Nitzsche; Kathrin D Geiger; Heinz-Adolf Schoon
Journal:  Transl Stroke Res       Date:  2011-08-23       Impact factor: 6.829

8.  A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats.

Authors:  Satoshi Iihoshi; Osamu Honmou; Kiyohiro Houkin; Kazuo Hashi; Jeffery D Kocsis
Journal:  Brain Res       Date:  2004-05-08       Impact factor: 3.252

Review 9.  Themes and strategies for studying the biology of stroke recovery in the poststroke epoch.

Authors:  S Thomas Carmichael
Journal:  Stroke       Date:  2008-02-28       Impact factor: 7.914

10.  Nitric oxide facilitates delivery and mediates improved outcome of autologous bone marrow mononuclear cells in a rodent stroke model.

Authors:  Mallikarjunarao Kasam; Bing Yang; Roger Strong; Krystal Schaar; Vivek Misra; Xiaopei Xi; James C Grotta; Jaroslaw Aronowski; Sean I Savitz
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240
View more
  8 in total

Review 1.  Developing Cellular Therapies for Stroke.

Authors:  Sean I Savitz
Journal:  Stroke       Date:  2015-06-04       Impact factor: 7.914

2.  CXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in mice.

Authors:  Jianping Wang; Xi Liu; Hong Lu; Chao Jiang; Xiaobing Cui; Lie Yu; Xiaojie Fu; Qian Li; Jian Wang
Journal:  Brain Behav Immun       Date:  2014-12-16       Impact factor: 7.217

3.  3K3A-activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice.

Authors:  Yaoming Wang; Zhen Zhao; Sanket V Rege; Min Wang; Gabriel Si; Yi Zhou; Su Wang; John H Griffin; Steven A Goldman; Berislav V Zlokovic
Journal:  Nat Med       Date:  2016-08-22       Impact factor: 53.440

4.  Behavioral and histopathological assessment of adult ischemic rat brains after intracerebral transplantation of NSI-566RSC cell lines.

Authors:  Naoki Tajiri; David M Quach; Yuji Kaneko; Stephanie Wu; David Lee; Tina Lam; Ken L Hayama; Thomas G Hazel; Karl Johe; Michael C Wu; Cesar V Borlongan
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

5.  Cryopreservation of Bone Marrow Mononuclear Cells Alters Their Viability and Subpopulation Composition but Not Their Treatment Effects in a Rodent Stroke Model.

Authors:  Bing Yang; Kaushik Parsha; Krystal Schaar; Nikunj Satani; Xiaopei Xi; Jaroslaw Aronowski; Sean I Savitz
Journal:  Stem Cells Int       Date:  2016-06-15       Impact factor: 5.443

6.  Continuous administration of a p38α inhibitor during the subacute phase after transient ischemia-induced stroke in the rat promotes dose-dependent functional recovery accompanied by increase in brain BDNF protein level.

Authors:  John J Alam; Michael Krakovsky; Ursula Germann; Aharon Levy
Journal:  PLoS One       Date:  2020-12-04       Impact factor: 3.240

Review 7.  Activated protein C, protease activated receptor 1, and neuroprotection.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2018-06-04       Impact factor: 25.476

8.  Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials.

Authors:  Francisco Moniche; Paulo Henrique Rosado-de-Castro; Irene Escudero; Elena Zapata; Francisco Javier de la Torre Laviana; Rosalia Mendez-Otero; Magdalena Carmona; Pilar Piñero; Alejandro Bustamante; Lucía Lebrato; Juan Antonio Cabezas; Alejandro Gonzalez; Grabriel R de Freitas; Joan Montaner
Journal:  Stem Cells Int       Date:  2016-07-21       Impact factor: 5.443
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.